Trial Profile
A Retrospective chart analysis of Mirabegron as an alternative treatment in Neurogenic detrusor overactivity patients with spinal cord injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 16 Nov 2016 New trial record